CD274 and Peripheral edema: Those all indicated that PD-1/PD-L1 inhibitors had better safety and weaker toxicities.[11–42] In conclusion, the effect of PD-1/PD-L1 inhibitor on the risk of developing peripheral edema was weaker than that of chemotherapy, and the combination with chemotherapy slightly increased the incidence risk of peripheral edema.